<DOC>
	<DOCNO>NCT01758861</DOCNO>
	<brief_summary>Acute kidney injury ( AKI ) frequently occur cardiac surgery use cardiopulmonary bypass ( CPB ) . Recombinant human erythropoietin ( rHuEPO ) know provide organ protection ischemia-reperfusion injury anti-inflammatory property . The aim present study investigate effect single preoperative bolus EPO incidence AKI follow complex valvular heart surgery randomize , control double-blind trial .</brief_summary>
	<brief_title>Effect Erythropoietin Incidence Acute Kidney Injury Following Complex Valvular Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>preoperative risk factor AKI schedule complex valvular heart operation Enrolled criterion high risk AKI patient 2 bellow : female , serum creatinine &gt; 1.2 mg/dl , preoperative Afib , GFR &lt; 60 ml/min , NYHA class IV , HTN , DM , age &gt; 65 year , peripheral vascular disease . Complex valvular heart operation define doublevalve surgery , combine valve coronary artery bypass grafting procedure , Bentall operation , combine mitral valve surgery tricuspid annuloplasty reoperation . Patients preexist uncontrolled hypertension ( diastolic blood pressure &gt; 100 mmHg ) , immunosuppression , history thromboembolism , malignant disease , seizure , liver dysfunction , renal impairment ( serum creatinine &gt; 2 mg/dL ) , drug alcohol abuse exclude .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Erythropoietin</keyword>
	<keyword>acute kidney injury</keyword>
	<keyword>valvular heart surgery</keyword>
</DOC>